Peijia Medical-B (09996) received an increase in the company's shares by no more than HK$15 million by Chairman Zhang Yi

According to the Zhitong Finance App, Peijia Medical-B (09996) issued an announcement. The board of directors learned that Dr. Zhang Yi, executive director, CEO and chairman of the company's board of directors, began purchasing the company's shares on the open market through the company he controls on December 1, 2025. The total cost of increased shareholding is expected to be no more than HK$15 million.

According to Dr. Zhang, the increase in shareholding reflects its recognition of the company's intrinsic value and its firm confidence in the company's development prospects and growth potential. Dr. Cheung will not rule out the possibility of further increasing his shareholding in the company in due course in accordance with applicable laws and regulations.